First, 12 randomly selected participants were randomly divided into two groups each comprising six members and assigned to receive a single oral dose of anastrozole 0.5 or 1mg after a fast of 10 ...

The study was a multicentre, randomised, non-blinded, parallel-group trial of 0.5 and 1mg/day of anastrozole and approved by the Institutional Review Board in each of the 30 participating centres.

Doctors often use hormone therapy to treat breast cancer. One of the drugs they commonly use is called anastrozole. Researchers are looking for ways to improve standard treatments. In this study, they ...

Athletes from Mauritius and the United States, are facing disciplinary action after testing positive for banned substances during in-competition ...

Breast cancer patients whose tumors have spread to other parts of their bodies live from scan to scan. Is their treatment working? Or will they learn their cancer is growing again? But a new study ...

Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib ...

The trial evaluated switching to the camizestrant combination versus continuing standard-of-care treatment with an aromatase inhibitor (AI) (anastrozole or letrozole) in combination with a CDK4/6 ...

A month after the Eastern Cape Department of Health promised that they had paid the overdue bills that delayed the delivery of chemotherapy drugs to Nelson Mandela Bay hospitals and that the issue ...

Do not take ARIANNA 1 if you are allergic to: Anastrozole, the active ingredient of ARIANNA 1 Any of the other ingredients in ARIANNA 1, as listed at the end of this leaflet Other anti-estrogen ...

Almost 30 years after it was first licensed as a treatment for breast cancer, aromatase inhibitor anastrozole has been cleared for preventive use in women at high risk of developing the disease in ...